BiomX Inc

ASE:PHGE   4:00:00 PM EDT
0.23
-0.03 (-10.06%)
Earnings Announcements

Biomx Reports Q3 Loss of $0.23 Per Share

Published: 11/09/2022 11:55 GMT
BiomX Inc (PHGE) - Biomx Reports Third Quarter 2022 Financial Results and Provides Business Update.
Biomx Inc - Cash Runway Through at Least Mid-2024.
Biomx Inc - Qtrly Loss per Share $0.23.
Biomx Inc - Continued Progress Enrolling Patients in Phase 1/2 Trial of Bx004 for Treatment of Lung Infections in Cystic Fibrosis.
Biomx Inc - Results From Part 1 of Phase 1/2 Trial of Bx004 Now Expected in Q1 2023.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.23

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.19

More details on our Analysts Page.